New derivatives of phenothiazines with anticancer activities;Nowe 1ochodne fenotiazyn o wlaściwościach przeciwnowotworowych

Polski Merkuriusz Lekarski

Volumn 26, Issue 156, 2009, Pages 671-675

  Morak Mlodawska, B ^a,b,c   Jelen, M ^a,b   Pluta, K ^a,b  

^a Katedra i Zaklad Chemii Organicznej w Sosnowcu   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Katedra i Zaklad Chemii Organicznej   (Poland)

Author keywords

Anticancer activity; Azaphenothiazines; Gl 50; Phenothiazines; TGI i LC 50

Indexed keywords

ANTINEOPLASTIC AGENT; PHENOTHIAZINE DERIVATIVE;

ANIMAL; CHEMISTRY; DRUG EFFECT; HELA CELL; HUMAN; REVIEW; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; HELA CELLS; HUMANS; PHENOTHIAZINES; TUMOR CELLS, CULTURED;

EID: 67651167090     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Amaral L., Kristiansen J.E.: Phenothiazines: potential management of Creutzfeld-Jacob disease and its variants. Int. J. Antimicrob. Agents, 2001, 18,411-417.
2. Amaral L., Viveiros M., Kristiannsen E.: Phenothiazines: potential alternatives for the management of antibiotics resistant infections of tuberculosis and malaria in developing countries. Trop. Med. Int. Health, 2001, 12, 1016-1022.
3. Azuine M.A., Tokuda H., Takayasu J. i wsp.: Cancer chemopreventive effect of phenothiazines and related triheterocyciic analogues in the 12tetradecanoylphorbal-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcenogenesis models. Pharm. Res., 2004, 49, 161-169.
4. Bednarska-Czerwińska A., Dabkowska-Huc A., Skalba P.: Receptor androgenowy. Gin. Prakt., 2003, 11, 12-18.
5. Bisson W.H., Cheltsov A.V., Bruey-Sedano N. i wsp.: Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. PNAS, 2007, 104, 11927-11932.
6. Gupta R.R., Kumar M.: Synthesis, properties and reactions of phenothiazines. W: Phenothiazines and 1,4-Benzothiazines - Chemical and Biomedical Aspects. Gupta R.R. (red.). Amsterdam, Elsevier, 1988, 1-146.
7. Jelen M., Pluta K.: Synthesis of 6-aminoalkyldiquino-1,4-thiazines and their acyl and sulfony derivatives. Heterocycles, 2008, 75, 859-870.
8. Kleszczewska E., Hejna J.: Zastosowanie farmakoterapii w leczeniu schizofrenii za pomoca klasycznych neuroleptyków z grupy pochodnych fenotiazyny. Pol. Merk. Lek., 2003, 80, 136-138.
9. Kurihara T., Motohashi N., Pang G.L. i wsp.: Correlation between topological resonance energy of metyl-substituted benzo[a]jphenothiazines, benzfcjacridines and their carcinogenic or antitumor activities. Anticancer Res., 1996, 16, 2757-2766.
10. Mayur Y.C., Jagadeesh S., Thimmaiah K.N.: Targeting calmodulin in reversing multi drug resistance in cancer cells. Mini Rev. Med. Chem., 2006, 6, 1383-1389.
11. Mitchell S.C.: Phenothiazine: The parent molecule. Curr. Drug Targets, 2006, 7, 1181-1189.
12. Morak-Mlodawska B., Jelen M.: Nowe wlasciwosci biologiczne neuroleptycznych fenotiazyn. Pol. Merk. Lek., 2007, 138, 459-462.
13. Morak-Mlodawska B., Pluta K.: Synthesis of novel dipyrido-1,4-thiazines. Heterocycles, 2007, 71, 1347-1361.
14. Mosnaim A.D., Ranade V.V., Wolf M.E. i wsp.: Phenothiazine molecule the basic chemical structure for various classes of pharmacotherapeutic agents. Am. J. Therapeutics, 2006, 13, 261-273.
15. Motohashi N.: Antitumor activities of phenothiazines. W: Phenothiazines and 1,4-Benzothiazlnes - Chemical and Biomedical Aspects. Gupta R.R. (red.). Amsterdam, Elsevier, 1988, 705-770.
16. Motohashi N., Kawase M., Saito S. i wsp.: Synthesis and biological activity of N-acylphenothiazines. Int. J. Antlmicrob. Agents, 2000, 14, 203-207.
17. Motohashi N., Kawase M., Saito S. i wsp.: Antitumor potential and possible targets of phenothiazine-related compounds. Curr. Drug Targets, 2000, 1,237-245.
18. Motohashi N., Kawase M., Kurihara T. i wsp.: Synthesis and antitumor activity of 1-[2-(chloroethyl)-3-(-substituted-10H-phenothiazin-10-yl)]alkyl- 1ureas as potent anticancer agents. Anticancer Res., 1996, 16, 2525-2532.
19. Motohashi N., Kawase M., Satoh K. i wsp.: Cytotoxic potential of phenothiazines. Curr. Drug Targets, 2006, 7, 1055-1066.
20. Motohashi N., Kurihara T., Sakagami H. I wsp.: Chemical structure and tumor type specificity of "half" phenothiazines. Anticancer Res., 1999, 19, 1859-1864.
21. Nagy S., Argyelan G., Moinar J. i wsp.: Antitumor activity of phenothiazine-related compounds. Anticancer Res., 1996, 16, 1915-1918.
22. Nordenberg J., Fenig E., Landau M. i wsp.: Effects of psychotropic drugs on cell proliferation and differation. Biochem. Pharmacol., 1999, 58, 1229-1236.
23. Nowak M., Pluta K., Suwiňska K. i wsp.: Synthesis of new pentacyclic diquinothiazines. J. Heterocyclic Chem., 2007, 44, 543-550.
24. Okumara H., Nakazawa J., Tsuganezawa K. i wsp.: Phenothiazine and carbazole-related compounds Inhibit mitotic kinesin Eg5 and trigger apoptosis in transformed culture cells. Toxycology Lett., 2006, 166, 44-52.
25. Pawlicki M., Wiczynska B.: Nowe leki przeciwnowotworowe - postep czy stagnacja? Nowotwory J. Oncol., 2001, 51, 507-514.
26. Pluta K., Morak-Mlodawska B., Jelen M.: National Cancer Institute, Development Therapeutics Program, In vitro Testing Results. Bethesda, USA.
27. Pollmächer T., Hack M.: Effects of antipsychotic drugs on cytokine networks. J. Psych. Res., 2000, 34, 369-382.
28. Wuonola M., A., Palfreyman M., G., Motohashi N. i wsp.: The primary in vitro antitumor screening of half-mustard type phenothiazines. Anticancer Res., 1997, 17, 3409-3423.
29. Wuonola M., A., Palfreyman M., G., Motohashi N. i wsp.: The in vitro antitumor assay of half-mustard type phenothiazines in screens of AIDS-related leukemia and lymphomas. Anticancer Res., 1997, 17, 3425-3429.
30. Zajac M., Pawelczyk E., Jellnska A.: Chemia leków. AM, Poznan 2006.
31. Zhelev Z., Ohba H., Bakalova R. i wsp.: Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia. Cancer Chemother. Pharmacol., 2004, 53, 267-275.